Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their efficacy and safety.
Related Posts
Buy this burger chain with more than 40% upside, says Loop Capital
The burger stock has little tariff risk, according to Loop Capital.
Quantum computing is having a moment. But the technology remains futuristic
Quantum technology startups attracted about $2 billion in 2024, according to McKinsey & Co.
Watch Fed Chair Powell testify live on interest rate policy before House committee
In prepared remarks, Powell said concerns linger over the impact President Donald Trump’s tariffs will have on inflation.